{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:10:04Z","timestamp":1792300204113,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.cjca.2010.12.035","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T15:45:58Z","timestamp":1302882358000},"page":"339-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Myocardial Alterations in the Murine Model of Fabry Disease Can Be Reversed by Enzyme Replacement Therapy"],"prefix":"10.1016","volume":"27","author":[{"given":"Paula A.","family":"Rozenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo J.","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2010.12.035_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2010.12.035_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry\u2032s disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2010.12.035_bib3","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2010.12.035_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.CIR.54.5.818","article-title":"Cardiac valvular anomalies in Fabry disease","volume":"54","author":"Desnick","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.035_bib5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1067\/mhj.2000.105105","article-title":"New insights in cardiac structural changes in patients with Fabry's disease","volume":"139","author":"Linhart","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2010.12.035_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.ATV.0000209649.60409.38","article-title":"Cardiac and vascular hypertrophy in Fabry disease","volume":"26","author":"Barbey","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2010.12.035_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.hco.0000131534.25034.43","article-title":"Tissue Doppler imaging in Fabry disease","volume":"19","author":"Pieroni","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2010.12.035_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease","volume":"417","author":"Elleder","year":"1990","journal-title":"Virch Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.cjca.2010.12.035_bib9","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2353\/ajpath.2008.070576","article-title":"Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease","volume":"172","author":"Chimenti","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cjca.2010.12.035_bib10","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"Alpha-galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cjca.2010.12.035_bib11","first-page":"67","article-title":"Preclinical studies with plant-produced \u03b1-galactosidase A in Fabry mice show potential for replacement therapy","volume":"2","author":"Gelderman","year":"2004","journal-title":"Preclinica"},{"key":"10.1016\/j.cjca.2010.12.035_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/HYPERTENSIONAHA.107.087759","article-title":"Phosphodiesterase 5A inhibition induces Na+\/H+ exchanger blockade and protection against myocardial infarction","volume":"49","author":"Perez","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2010.12.035_bib13","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.222221899","article-title":"Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer","volume":"99","author":"Takahashi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cjca.2010.12.035_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1361-8415(03)00011-2","article-title":"Cardiac magnetic resonance in small animal models of human heart failure","volume":"7","author":"Nahrendorf","year":"2003","journal-title":"Med Image Analysis"},{"key":"10.1016\/j.cjca.2010.12.035_bib15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.RES.49.3.618","article-title":"Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction: effects on systolic function","volume":"49","author":"Fletcher","year":"1981","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2010.12.035_bib16","first-page":"H1812","article-title":"Ventricular remodeling in a mouse model of myocardial infarction","volume":"274","author":"Patten","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2010.12.035_bib17","series-title":"Heart Disease: A Textbook of Cardiovascular Medicine","author":"Braunwald","year":"1981"},{"key":"10.1016\/j.cjca.2010.12.035_bib18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1253\/circj.70.1503","article-title":"Correction of cardiac abnormalities in Fabry mice by direct intraventricular injection of a recombinant lentiviral vector that engineers expression of \u03b1-galactosidase A","volume":"70","author":"Yoshimitsu","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2010.12.035_bib19","series-title":"Excitation-Contraction Coupling and Cardiac Contractile Force","author":"Bers","year":"2001"},{"key":"10.1016\/j.cjca.2010.12.035_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0008-6363(01)00544-2","article-title":"Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na \/H exchanger","volume":"53","author":"Camilion de Hurtado","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2010.12.035_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.HYP.0000051502.93374.1C","article-title":"Regression of hypertensive myocardial fibrosis by Na+\/H+ exchange inhibition","volume":"41","author":"Cingolani","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2010.12.035_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s10545-006-0360-6","article-title":"Extracellular matrix turnover and disease severity in Anderson-Fabry disease","volume":"30","author":"Shah","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2010.12.035_bib23","first-page":"H3057","article-title":"Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure","author":"Brower","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2010.12.035_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/ejechocard\/jen129","article-title":"Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy","volume":"9","author":"Kovacevic-Preradovic","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.cjca.2010.12.035_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2004.035584","article-title":"The natural history of left ventricular systolic function in Anderson-Fabry disease","volume":"91","author":"Shah","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2010.12.035_bib26","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study","volume":"108","author":"Weidemann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.035_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1540-8175.2006.00356.x","article-title":"Echocardiographic evaluation of ventricular function in mice","volume":"24","author":"Rottman","year":"2007","journal-title":"Echocardiography"},{"key":"10.1016\/j.cjca.2010.12.035_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.yjmcc.2009.07.004","article-title":"Ventricular remodeling and function: Insights using murine echocardiography","volume":"48","author":"Scherrer-Crosbie","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2010.12.035_bib29","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.echo.2008.07.001","article-title":"Echocardiography in translational research: of mice and men","volume":"21","author":"Scherrer-Crosbie","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2010.12.035_bib30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/gerona\/62.12.1319","article-title":"Cardiac function in young and old little mice","volume":"62","author":"Reddy","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.cjca.2010.12.035_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.carpath.2009.05.003","article-title":"A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy","volume":"19","author":"Sheppard","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjca.2010.12.035_bib32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.humpath.2006.01.021","article-title":"Histologic and electron microscopy findings in myocardium of treated Fabry disease","volume":"37","author":"Owens","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cjca.2010.12.035_bib33","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"Alpha-galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cjca.2010.12.035_bib34","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1161\/CIRCULATIONAHA.108.841494","article-title":"Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy","volume":"119","author":"Thurberg","year":"2009","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X10000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X10000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:36:33Z","timestamp":1760106993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X10000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0828282X10000516"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2010.12.035","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial Alterations in the Murine Model of Fabry Disease Can Be Reversed by Enzyme Replacement Therapy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2010.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}